Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 8/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 5/20 | 0.49 |
| ▸ | ALKBH2 | Q6NS38 | 1/20 | 0.48 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.48 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | P4HTM | Q9NXG6 | 2/20 | 0.43 |
| ▸ | KAT6A | Q92794 | 4/20 | 0.42 |
| ▸ | KMO | O15229 | 1/20 | 0.42 |
| ▸ | EGFR | P00533 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21317279 | 0.93 | PTGS2 (0.49) | PTGS2PTGS1ALKBH2ALKBH5FTO | |
| SCHEMBL21317305 | 0.90 | NR2E1 (0.46) | PTGS2PTGS1ALKBH2ALKBH5FTO | |
| SCHEMBL21317092 | 0.87 | PTGS2 (0.54) | PTGS2PTGS1ALKBH2ALKBH5FTO | |
| SCHEMBL21317262 | 0.86 | PTGS2 (0.50) | PTGS2PTGS1ALKBH2ALKBH5FTO | |
| SCHEMBL21317340 | 0.86 | PTGS2 (0.50) | PTGS2PTGS1ALKBH2ALKBH5FTO | |
| SCHEMBL21317328 | 0.85 | PTGS2 (0.52) | PTGS2PTGS1ALKBH2ALKBH5FTO | |
| SCHEMBL21317357 | 0.83 | PTGS2 (0.50) | PTGS2PTGS1ALKBH2ALKBH5FTO | |
| SCHEMBL21317170 | 0.82 | PTGS2 (0.52) | PTGS2PTGS1ALKBH2ALKBH5FTO | |
| SCHEMBL21317126 | 0.82 | HPGD (0.52) | PTGS2PTGS1ALKBH2ALKBH5FTO | |
| SCHEMBL21317193 | 0.82 | PTGS2 (0.56) | PTGS2PTGS1ALKBH2ALKBH5FTO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10820591-B2 | Substituted sulfonyl amides for controlling animal pests | BAYER AKTIENGESELLSCHAFT (DE) | 2020-11-03 | — | — | US | disclosed |
| US-20190269134-A1 | SUBSTITUTED SULFONYL AMIDES FOR CONTROLLING ANIMAL PESTS | BAYER AKTIENGESELLSCHAFT (DE) | 2019-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190269134-A1 | SUBSTITUTED SULFONYL AMIDES FOR CONTROLLING ANIMAL PESTS | MLYCD, STOM, DDT | PTGS2 3333/4885PTGS1 3491/4885ALKBH2 3142/4885 |
| US-10820591-B2 | Substituted sulfonyl amides for controlling animal pests | MLYCD, STOM, DDT | PTGS2 3333/4885PTGS1 3491/4885ALKBH2 3142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.